Haemonetics Corporation (NYSE:HAE) Q4 2023 Earnings Conference Call May 11, 2023 8:00 AM ET Company Participants David Trenk - Manager, Investor Relations Christopher Simon - Chief Executive Officer James D'Arecca - Executive Vice President and Chief Financial Officer Conference Call Participants Anthony Petrone - Mizuho Larry Solow - CJS Securities David Turkaly - JMP Securities Mike Matson - Needham & Company Drew Ranieri - Morgan Stanley Michael Petusky - Barrington Research Operator Good day and thank y ...

Haemonetics Corporation (NYSE:HAE) Q3 2023 Earnings Conference Call February 7, 2023 8:00 AM ET Company Participants David Trenk - Manager, Investor Relations Chris Simon - Chief Executive Officer Roy Galvin – President, Global Plasma and Blood Center James D'Arecca - Chief Financial Officer Conference Call Participants Drew Ranieri - Morgan Stanley Mike Matson - Needham & Company Joanne Wuensch - Citi Anthony Petrone - Mizuho Andrew Cooper - Raymond James Dave Turkaly - JMP Operator Good day, and welcome t ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF ☒ 1934 For the quarterly period ended: December 31, 2022 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF ☐ 1934 Commission File Number: 001-14041 HAEMONETICS CORPORATION (Exact name of registrant as specified in its charter) Massachusetts 04-2882273 (State or other jurisdiction of (I.R.S. Employer incorpora ...

Haemonetics Corporation JP Morgan 41st Annual Healthcare Conference January 10, 2023 Important Information Safe Harbor for Forward-Looking Statements 2 This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forwardlooking statements do not relate strictly to historical or current facts and may be identified by the use of words such as "may," "will," "should," "could," "would," "expects," "p ...

Haemonetics Corporation (NYSE:HAE) Q2 2023 Earnings Conference Call November 7, 2022 8:00 AM ET Company Participants Olga Guyette - Director, Investor Relations and Treasury Chris Simon - Chief Executive Officer Stewart Strong - President of Global Hospital Business James D'Arecca - Chief Financial Officer Conference Call Participants Anthony Petrone - Mizuho Drew Ranieri - Morgan Stanley Andrew Cooper - Raymond James David Turkaly - JMP Securities Mike Matson - Needham & Company Operator Good day, and welc ...

Haemonetics Corporation Morgan Stanley 20th Annual Global Healthcare Conference September 12, 2022 © 2022 Haemonetics Corporation IMPORTANT INFORMATION 2 Safe Harbor for Forward-Looking Statements This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements do not relate strictly to historical or current facts and may be identified by the use of words such as "may," "wi ...

Haemonetics Corporation (NYSE:HAE) Q1 2023 Earnings Conference Call August 10, 2022 8:00 AM ET Company Participants Olga Guyette - Director, IR and Treasury Chris Simon - CEO James DÂ'Arecca - CFO Conference Call Participants Larry Solow - CJS Securities Drew Ranieri - Morgan Stanley Andrew Cooper - Raymond James Mike Matson - Needham & Company Michael Petusky - Barrington Research David Turkaly - JMP Securities Anthony Petrone - Mizuho Securities Operator Good day, and welcome to Haemonetics Corporation's ...

Haemonetics Corporation (NYSE:HAE) Q4 2022 Results Conference Call May 10, 2022 8:00 AM ET Company Participants Olga Guyette - Director, IR and Treasury Chris Simon - CEO James DÂ'Arecca - CFO Conference Call Participants Larry Solow - CJS Securities Drew Ranieri - Morgan Stanley Andrew Cooper - Raymond James Mike Matson - Needham & Company David Turkaly - JMP Securities Operator Good morning, ladies and gentlemen. Thank you for standing by, and welcome to Haemonetics Corporation Fourth Quarter Fiscal 2022 ...

Haemonetics Corporation Raymond James 43rd Institutional Investors Conference March 7-8, 2022 © 2022 Haemonetics Corporation Forward-Looking Statements Any statements contained in this presentation that do not describe historical facts may constitute forward-looking statements. Forward-looking statements in this presentation may include, without limitation, statements regarding (i) plans and objectives of management for operations of Haemonetics Corporation (the "Company"), including plans or objectives rel ...

Haemonetics Corporation (NYSE:HAE) Q3 2022 Results Conference Call February 8, 2022 8:00 AM ET Company Participants Olga Guyette - Director, IR Christopher Simon - President, CEO William Burke - CFO Conference Call Participants Zach Weiner - Jefferies Andrew Cooper - Raymond James Mike Matson - Needham & Company Drew Ranieri - Morgan Stanley Larry Solow - CJS Securities Operator Good day, and thank you for standing by. Welcome to the Haemonetics Corporation's Third Quarter Fiscal 2022 Earnings Call. [Operat ...